Host Modulators of H1N1 Cytopathogenicity

Influenza A virus infects 5–20% of the population annually, resulting in ∼35,000 deaths and significant morbidity. Current treatments include vaccines and drugs that target viral proteins. However, both of these approaches have limitations, as vaccines require yearly development and the rapid evolut...

Full description

Bibliographic Details
Main Authors: Ward, Samuel E., Kim, Hyun Seok, Komurov, Kakajan, Mendiratta, Saurabh, Tsai, Pei-Ling, Schmolke, Mirco, Satterly, Neal, Manicassamy, Balaji, Forst, Christian V., Roth, Michael G., García-Sastre, Adolfo, Blazewska, Katarzyna M., McKenna, Charles E., Fontoura, Beatriz M., White, Michael A.
Format: Online
Language:English
Published: Public Library of Science 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410888/